pharma news today obesity drugs glp-1 Drug Market: the rapid growth of the diabetes and market Race for approval of first
Description
For people with lupus, this added benefit could be an important consideration, particularly if they have other risk factors for heart disease
This underscores Wegovys efficacy as a tool for significant, sustained weight reduction
[DOI] [Google Scholar] 31.Chen Z., Zhang N., Chu H
Clin Res Cardiol (2025)
Not sure if you qualify
